VALNEVA
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-05-13
Analyst
Guggenheim Partners
Equibles does not estimate personal net worth.
Pamil Divan is recorded as Analyst at Guggenheim Partners. Pamil Divan has spoken on 2 earnings calls across 2 companies, most recently for VALNEVA on May 13, 2026. Those appearances were for VALNEVA and Valneva SE (VALN). The companies whose calls Pamil Divan spoke on are classified in the Healthcare sector.
“And maybe a couple more on the Lyme front. And I appreciate you may not be able to answer all these fully right now. But one, I'm curious when we would actually, when you think the full data would be released for us to review it in totality.”
“And maybe a couple more on the Lyme front. And I appreciate you may not be able to answer all these fully right now. But one, I'm curious when we would actually, when you think the full data would be released for us to review it in totality.”
Guggenheim Partners
Analyst
Transcript header (unverified)
VALNEVA
Biotechnology · Healthcare
VALN
Biotechnology · Healthcare
Q1 2026 Financial Results
VALNEVA